Upon completion of the video presentation, to finish the activity and claim your credit, please click here.

This activity is supported by an educational grant from Genentech.

Nuances in the Management of Aggressive Lymphomas

Paul A. Hamlin, MD
Memorial Sloan Kettering Cancer Center

Michelle Wisniewski, PA
Memorial Sloan Kettering Cancer Center

Treatment for both Hodgkin and non-Hodgkin’s lymphoma now includes chemotherapy, targeted therapy, and new immunotherapies. As research continues to shine the light on tumor genetics, clinical variability, and new treatment approaches, advanced practitioners (APs) need to translate this information to the bedside in the management of aggressive lymphomas. This educational activity will provide APs with the latest update on emerging treatments for aggressive, relapsed/refractory lymphomas, as well as potential adverse events and how to manage them, with the goal of optimizing treatment effectiveness and patient outcomes.


Download Podcast


Download Transcript


Download Slides


Download Slides & Transcripts


These CME/CE/CPE accredited activities are jointly provided by

JADPRO CE Logo Harborside Press Logo APSHO Logo Annenberg Logo
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here